Mitotic catastrophe cell death induced by heat shock protein 90 inhibitor in BRCA1-deficient breast cancer cell lines

Molecular Cancer Therapeutics
Magdalena ZajacBeatriz Martínez-Delgado

Abstract

Heat shock protein 90 (Hsp90) is a molecular chaperone involved in folding, assembly, maturation, and stabilization of the client proteins that regulate survival of malignant cells. As previous reports correlate high Hsp90 expression with decreased survival in breast cancer, Hsp90 may be a favorable target for investigational therapy in breast cancer. In our study, we have examined the response of a panel of both BRCA1-null (UACC 3199, HCC 1937, and MBA-MD-436) and BRCA1-wt breast cancer cell lines (MCF-7, MBA-MD-157, and Hs578T) to determine the proteins governing response to Hsp90 inhibitor 17-allyloamino-17-demethoxy-geldanamycin. On treatment with the drug, cells arrested at G(2)-M phase and entered aberrant mitosis in a BRCA1-dependent manner. Failure to arrest the cells at or before mitosis resulted in formation of micronucleated cells, aberrant segregation of chromosomes, microtubule misalignment, and multicentrosomes, leading in eventual mitotic catastrophe cell death. Our observations show that BRCA1 mediates G(2)-M transition mainly through chek1 on 17-allyloamino-17-demethoxy-geldanamycin treatment.

References

Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Feb 12, 2002·Nature Genetics·Ronit I YardenLawrence C Brody
Dec 13, 2002·Cell Death and Differentiation·M CastedoG Kroemer
Oct 23, 2003·The Journal of Biological Chemistry·Sonnet J H ArlanderLarry M Karnitz
Nov 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Paola FortugnoDario C Altieri
Apr 13, 2004·Oncogene·Maria CastedoGuido Kroemer
Sep 25, 2004·Journal of Cellular Physiology·Motohiro NomuraDavid Zagzag
Jan 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xingxu HuangPumin Zhang
Aug 4, 2005·The Journal of Biological Chemistry·Sandy D Westerheide, Richard I Morimoto
Oct 20, 2005·Blood·Constantine S MitsiadesKenneth C Anderson
Nov 1, 2005·Cell Cycle·Insoo BaeEliot M Rosen
Nov 12, 2005·Journal of Cancer Research and Clinical Oncology·Megumi SenjuEisaburo Sueoka
Apr 6, 2007·Cancer Research·Elah PickHarriet M Kluger
May 31, 2007·Journal of Biosciences·Len Neckers
Jul 10, 2007·Cancer Research·Kazuhiko YamaneTimothy J Kinsella

❮ Previous
Next ❯

Citations

Nov 27, 2010·International Journal of Oncology·Paul L ReganXao X Tang
Feb 5, 2013·Biochemical and Biophysical Research Communications·Tomoyuki OsawaKen-Ichi Yoshioka
Jan 10, 2012·Biochimica Et Biophysica Acta·Luke Whitesell, Nancy U Lin
Jun 24, 2009·Molecular Oncology·Shai White-GilbertsonChristina Voelkel-Johnson
Aug 23, 2011·Biochimica Et Biophysica Acta·Mehdi Mollapour, Len Neckers
Apr 25, 2019·Apoptosis : an International Journal on Programmed Cell Death·Tidarat NhukeawAdisorn Ratanaphan
Oct 20, 2011·Molecular Cancer Research : MCR·Arun AzadBenjamin Solomon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.